MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517067567 A) filed by Eli Lilly And Company, Indianapolis, on July 15, for 'novel rna therapeutics and uses thereof.'
Inventor(s) include Antonellis, Patrick Joseph; Beyer, Thomas Patrick; Branttie, Jean Mawuena; Cheng, Christine Chih-Tao; Debets, Marjoke F.; Gavardinas, Konstantinos; Lackner, Gregory Lawrence; Wang, Jibo; and Wilson, Takako.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to novel therapeutic compounds, known as RNAi agents, that decrease expression of the HMGCR receptor (expressed by the HMGCR...